AP FACT CHECK: Trump, American exceptionalism and the virus

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks dbergh #34616
148
AP FACT CHECK: Trump, American exceptionalism and the virus

By CALVIN WOODWARD, HOPE YEN and DAVID RISING an hour ago

WASHINGTON (AP) — Americans normally hear from President Donald Trump when he is opining on Twitter, riffing from a rally stage or otherwise improvising. This past week was different as he sat in the Oval Office with a script laid out for him to read on a matter grave enough for a prime-time address to the nation.

He addressed the coronavirus crisis .. https://apnews.com/VirusOutbreak .. that is spreading germs and fear.

But his words were as factually fraught as many of his tweets.

Most broadly, Trump hailed American exceptionalism in health care and science — “The virus will not have a chance against us” — even as the public health system failed in making diagnostic testing accessible to all who need it.

It’s been more than a week now since Trump assured the country: “Anybody, right now, and yesterday, anybody that needs a test, gets a test. They’re there. They have the test. And the test is beautiful.”

He persisted with that thought as recently as Thursday, a day after his Oval Office address, when he asserted “the testing has been going very smooth.” This, as the government’s top infection expert, Dr. Anthony Fauci, was telling lawmakers: “It is a failing, let’s admit it.”

A review of Trump’s recent rhetoric:

EXCEPTIONALISM?

TRUMP: “No nation is more prepared or more resilient than the United States.” — Oval Office address Wednesday.

THE FACTS: American resilience will be measured over time. But the U.S. is not more prepared than all other countries. Seven weeks since the first U.S. case of coronavirus was announced, the government cannot account for what could be thousands of additional infections because of continuing stumbles on testing.

Nearly a month after U.S. health officials promised to tap into a national network of labs that monitor for flu, that system is only just getting started. Large-scale testing is a critical part of tracking the spread of infectious diseases and allocating resources for treatment. The lack of comprehensive figures means U.S. health providers could quickly be overwhelmed by undetected cases.

Fauci told a congressional hearing that other countries grappling with the virus have been making it easy for people to get tested, but in the U.S., “the system is not really geared to what we need right now.”

For most people, COVID-19 causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover from it.

___

TRUMP: “If an American is coming back or anybody is coming back, we’re testing. We have a tremendous testing setup where people coming in have to be tested. ... We’re not putting them on planes if it shows positive, but if they do come here, we’re quarantining. There’s going to be a pretty strong enforcement of quarantine.” -- remarks Thursday.

THE FACTS: That’s not true. All people coming to the U.S. are not subject to mandatory, universal testing, nor are they being forced to quarantine.

As well, his proclamation detailing the broad travel restrictions that took effect midnight Friday night on visitors from most of Europe does not specify that everyone allowed in will have to be tested. Trump was probably referring to plans that are expected to be put in place soon to channel those arriving from many European countries to certain U.S. airports, where they will receive screening and be subjected to quarantine instructions, just like visitors from China.

___

TRUMP: “Taking early intense action, we have seen dramatically fewer cases of the virus in the United States than are now present in Europe. ” — Oval Office address.

THE FACTS: “Seen” so far may be true. But that does not mean Europe is being hit harder by infections than the United States. Because of test shortages in the U.S., many Americans with COVID-19 aren’t being diagnosed and counted.

___

TRUMP: “The European Union failed to take the same precautions and restrict travel from China and other hot spots. As a result, a large number of new clusters in the United States were seeded by travelers from Europe.” — Oval Office address.

THE FACTS: That’s a distorted account of travel restrictions in Europe.

By the time U.S. travel restrictions were announced on Jan. 31, many major European airlines had already cut service to China. While restrictions in some European countries were not as widespread, others were much broader.

The Czech Republic had stopped issuing visas to Chinese citizens. Germany issued a travel advisory urging citizens to postpone nonessential travel to China. Italy had declared a state of emergency for six months. Russia had shut down its land border with China, as well as almost all train traffic and most flights there.

Trump on Jan. 31 signed an order that would temporarily bar entry to the U.S. of foreign nationals, other than immediate family of U.S. citizens and permanent residents, who have traveled in China within the last 14 days. The ban took effect Feb. 2.

A recent study from the journal Science found China’s internal crackdown modestly delayed the spread of the virus but it cast doubt that travel restrictions elsewhere will do much compared with other preventive measures.

Despite Trump’s boast of “early intense action,” his former homeland security adviser, Tom Bossert, said restrictions on entry into the U.S. from Europe came too late. “We have nearly as much disease here in the US as the countries in Europe,” he tweeted.

___

WHAT’S COVERED

TRUMP: “Earlier this week, I met with the leaders of (the) health insurance industry, who have agreed to waive all co-payments for coronavirus treatments, extend insurance coverage to these treatments, and to prevent surprise medical billing.” — Oval Office address.

THE FACTS: No, they did not say they will cover copays for treatment.

As Vice President Mike Pence stated more accurately, the insurers agreed to cover coronavirus testing with no cost sharing — so no copays or deductibles. That assurance applies to tests that can confirm or rule out the virus, and doesn’t extend to treatment or to other tests that the patient’s doctor may order. Consumers should check with their insurance company because policies may vary on this. They should not count on the president’s word.

What’s more, in the process of diagnosing COVID-19, other tests may be ordered. Insurers have not pledged to waive cost-sharing for those. Copays and deductibles may apply for imaging tests such as X-rays or CT scans of the chest, for example, and hospital stays are also subject to cost-sharing.

Federal programs including Medicare, Medicaid, children’s health insurance and “Obamacare” all cover the coronavirus tests. Of particular importance, clinical diagnostic tests are covered under Medicare with no cost-sharing, a longstanding policy. But cost-sharing may apply for other tests, such as imaging.

When people get sick from the coronavirus, there currently is no antiviral treatment that can cure the disease. Instead, the current treatment is geared to relieving patients’ symptoms and helping them to recover. For those who are very sick, that can involve using machinery to help them breathe. Insurers cover such treatment based on the terms of the individual’s health plan, including any applicable deductibles and copays.

___

TESTS & TREATMENT

TRUMP: “We are cutting massive amounts of red tape to make antiviral therapies available in record time. These treatments will significantly reduce the impact and reach of the virus.” — Oval Office address.

THE FACTS: People with COVID-19 or those who get it in the outbreak should not expect those therapies to be available to them. Dr. Anthony Fauci of the National Institutes of Health told a congressional committee Wednesday that while antivirals are being tested, “we don’t know if it works. I don’t want to promise anything.”

An antiviral is a medicine that specifically attacks a virus to hasten recovery. An experimental drug named remdesivir, which was being developed to fight Ebola, is being tested in COVID-19 patients in the U.S. and abroad. There also are studies underway using combinations of some HIV-attacking drugs.

___

TRUMP: “For decades the @CDCgov looked at, and studied, its testing system, but did nothing about it. It would always be inadequate and slow for a large scale pandemic, but a pandemic would never happen, they hoped. President Obama made changes that only complicated things further..... Their response to H1N1 Swine Flu was a full scale disaster, with thousands dying, and nothing meaningful done to fix the testing problem, until now.” — tweets Friday.

THE FACTS: His newfound disdain for the CDC’s actions and his criticisms of the Obama administration are based on a faulty description of what happened in the 2009 H1N1 pandemic, initially called “swine flu.”

Then, the CDC’s flu surveillance network actually sounded the alarm, spotting two children in California who were the first diagnosed cases of the new flu strain. About two weeks later, the U.S. declared a public health emergency and the CDC began releasing anti-flu drugs from the national stockpile to help hospitals get ready. Trump declared a state of emergency Friday, nearly two months after the first COVID-19 case in the U.S. was announced.

As for thousands dying, it actually turned out that the new H1N1 strain was less deadly than average seasonal flu. But even that comparison is problematic because regular flu years are deadliest for the elderly while H1N1 was riskiest for younger people.

___

TRAVEL RESTRICTIONS

TRUMP: “We will be suspending all travel from Europe, except the United Kingdom, for the next 30 days.” — Oval Office address.

THE FACTS: He inaccurately described his own plan.

First, the restriction does not apply to legal permanent residents of the U.S. or their families when they are returning from Europe. It also does not apply to U.S. citizens coming back from Europe, as Trump acknowledged.

As well, it apparently does not apply to Ireland, Romania, Croatia, Ukraine and several other European states. The proclamation released by the White House says the travel ban affects the 26 European countries in the Schengen Area. That’s most of Europe, but not “all.”

___

TRUMP: “These prohibitions will not only apply to the tremendous amount of trade and cargo, but various other things as we get approval.” — Oval Office address.

THE FACTS: That is wrong. The White House quickly clarified that the restriction on movement from Europe “only applies to human beings, not goods and cargo.”

___

CHEAP GAS

TRUMP: “Good for the consumer, gasoline prices coming down!” — tweet Monday after the price of oil fell nearly 20% and the stock market, already shaken by the coronavirus outbreak, took an even deeper dive.

TRUMP: “So with gasoline prices coming down, that’s like a tax cut. Frankly, that’s like a big tax cut, not a little tax cut for the consumer. So there’s something about that that I like.” — remarks Thursday.

THE FACTS: His affection for cheaper prices at the pump is widely shared. It’s just that cheaper gas increasingly comes at a cost. The price decline could hurt overall economic growth, which is probably a bigger negative on balance than saving at the pump.

A drop in oil prices is not as helpful to the U.S. economy as it was when the country was massively dependent on foreign oil. That’s because the fracking revolution has made domestic oil and natural gas production a major part of the U.S. economy. A drop in prices hurts that domestic industry. It leads to less drilling, fewer jobs, cuts in factory orders and a host of aftershocks that could leave the nation as a whole worse off.

The last time oil prices dropped by a comparable amount, in 2015-2016, it contributed to a slowing of economic growth from 2.9% to 1.6%.

___

Rising reported from Berlin. Associated Press writers Lauran Neergaard, Ricardo Alonso-Zaldivar, Josh Boak, Jill Colvin, Colleen Long, and Zeke Miller in Washington and Tom Murphy in Indianapolis contributed to this report.

___

EDITOR’S NOTE — A look at the veracity of claims by political figures.

___

Find AP Fact Checks at http://apne.ws/2kbx8bd

https://apnews.com/19963ea122c12eb72b8f0ff14e84b1b7
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 19

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
CMS Proposal Sparks Controversy in Lab Certification

Updated Category News Views 8

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 7

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 8

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 2

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 5

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 12

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
JELD-WEN CFO Transition: Navigating Finances Amid Changes

Updated Category News Views 6

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 2

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nektar Therapeutics Announces Key Stock Option Grants for New Employees

Updated Category News Views 124

Nektar Therapeutics' New Stock Option Grants for Employees Nektar Therapeutics (NASDAQ: NKTR) has made an important announcement regarding the granting of stock options designed to attract new talent. Recently, their Board of Directors revealed that, under its 2025 Inducement Plan, they granted a considerable number of stock options aimed at supporting the interests of a...

Continue Reading
B2Gold Celebrates Successful Commercial Launch of Goose Mine

Updated Category News Views 157

Exciting Developments at the Goose Mine VANCOUVER, British Columbia -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) is thrilled to share that the Goose Mine has officially achieved commercial production, marking a significant milestone for the company. Production Milestone and Operations Update The declaration of commercial production at the Goose Mine came after...

Continue Reading
Tesla's Optimus Robot Advances in Autonomous Capabilities

Updated Category News Views 410

Tesla's Optimus Robot Takes Strides in Autonomy Tesla Inc. recently unveiled a captivating video showcasing its Optimus humanoid robot deftly navigating a factory environment. This demonstration emphasizes significant advancements in the robot's technology, particularly its autonomous navigation and charging capabilities. Robust Navigation Skills The latest video...

Continue Reading
monday.com Set to Reveal Financial Performance for 2024

Updated Category News Views 113

monday.com Financial Results Announcement monday.com (NASDAQ: MNDY), the innovative platform that enhances work management, has highlighted its commitment to transparency and investor engagement. The company has announced an upcoming report on its financial results for the fourth quarter and fiscal year 2024. This key announcement is scheduled for the morning of February...

Continue Reading
BioCryst Pharmaceuticals Holds Strong Position for Investors

Updated Category News Views 34

BioCryst Pharmaceuticals Maintains Strong Market Position Recently, BofA Securities reiterated its Buy rating for BioCryst Pharmaceuticals (NASDAQ:BCRX), maintaining a price target of $11.00. This assessment came on the heels of an encouraging third-quarter earnings report, where Orladeyo sales hit $116.3 million, surpassing expectations set by both BofA and market...

Continue Reading